Careers@GenerateBiomedicines
Generate Biomedicines
Summary
If you're interested in joining the Generate:Biomedicines team but don't see an opportunity that you'd like to apply to, please share your resume. We'll keep your information on file and will reach out if we find a match.
Job description
About Generate:Biomedicines
We are a clinical-stage generative biology company pioneering the AI revolution in drug design and development. We are advancing a new approach to drug creation—one grounded in the ability to design proteins with defined biological intent. By integrating machine learning with large-scale experimentation, this approach aims to reduce the uncertainty, time, and cost associated with developing protein-based medicines.
Founded in 2018, we are advancing a growing pipeline of clinical and preclinical programs across multiple disease areas and protein modalities. By unifying computational design and clinical development within a single operating model, we translate this approach into clinical-stage programs and are leading a shift from traditional drug discovery toward systematic drug generation.
At Generate:Biomedicines, we collaborate across disciplines in new ways to invent and innovate. We bring diverse perspectives to a shared goal of delivering better medicines to patients in need, faster, guided by our values and leadership behaviors.
Benefits
- Group Medical Insurance
- Vision Insurance
- Dental Insurance
- Group Life Insurance
- Disability Insurance
- 401(k) with Company Contribution
- Tuition Reimbursement
Company overview
Generate Biomedicines is a pioneering therapeutics company operating at the intersection of machine learning, biological engineering, and medicine. The company is revolutionizing drug discovery through its proprietary Generative Biology™ platform, which enables the on-demand generation of novel protein-based medicines across multiple therapeutic modalities. By studying millions of proteins to understand nature's functional encoding rules, Generate Biomedicines can design and create breakthrough medicines with unprecedented speed and success rates. The company's platform represents a fundamental shift in therapeutic development, moving beyond traditional discovery methods to programmed generation of biologics including antibodies, peptides, enzymes, and stealth proteins. With advanced AI algorithms and automated experimentation systems, Generate Biomedicines is advancing a pipeline of innovative therapies, including GB-0895 for severe asthma which is progressing to Phase 3 studies. As a Flagship Pioneering company, Generate Biomedicines combines cutting-edge computational biology with deep biological expertise to address humanity's most challenging diseases.